Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Liver Neoplasms × Ipilimumab × Clear all

Phase

Phase 1/2 3 Phase 1 3 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 15 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 7 Kidney Neoplasms 4 Stomach Neoplasms 3 Mesothelioma 3 Diabetes Mellitus, Insulin-Dependent, 12 3 Skin Neoplasms 2 Prostatic Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Various Advanced Cancer 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Non-Small Cell Lung Cancer Metastatic 1 Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Colonic Neoplasms 1

Interventions

Sorafenib 8 durvalumab 4 Cisplatin 4 Gemcitabine 3 Ethiodized Oil 3 Doxorubicin 3 Chemotherapy, Adjuvant 3 Bevacizumab 3 tremelimumab 2 phosphomannopentaose sulfate 2 Watchful Waiting 2 Talaporfin 2 Radiofrequency Ablation 2 Oxaliplatin 2 Nivolumab 2 Folfox protocol 2 Capecitabine 2 Analgesia, Patient-Controlled 2 sodium thiosulfate 1 seocalcitol 1 parecoxib 1 nolatrexed 1 linifanib 1 lenvatinib 1 ferumoxides 1 ferric carboxymaltose 1 contrast agent BR1 1 cabozantinib 1 brivanib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04340193 2024-11-26

CheckMate 74W

Bristol-Myers Squibb

Phase 3 Completed

26 enrolled 15 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡